Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Intangibles (2020 - 2025)

Bioventus' Intangibles history spans 6 years, with the latest figure at $368.4 million for Q4 2025.

  • For Q4 2025, Intangibles fell 8.97% year-over-year to $368.4 million; the TTM value through Dec 2025 reached $368.4 million, down 8.97%, while the annual FY2025 figure was $368.4 million, 8.97% down from the prior year.
  • Intangibles reached $368.4 million in Q4 2025 per BVS's latest filing, down from $377.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.1 billion in Q4 2022 to a low of $248.8 million in Q4 2021.
  • Average Intangibles over 5 years is $487.8 million, with a median of $447.6 million recorded in 2024.
  • Peak YoY movement for Intangibles: surged 324.29% in 2022, then tumbled 53.27% in 2023.
  • A 5-year view of Intangibles shows it stood at $695.2 million in 2021, then decreased by 7.96% to $639.9 million in 2022, then fell by 24.62% to $482.4 million in 2023, then fell by 16.09% to $404.7 million in 2024, then dropped by 8.97% to $368.4 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Intangibles are $368.4 million (Q4 2025), $377.4 million (Q3 2025), and $387.0 million (Q2 2025).